NOVARTIND

NOVARTIS INDIA

Small Cap BSE: 500672 NSE: NOVARTIND
₹707.95
4.6 (0.65%)
As on 13 August, 2022 | 06:01

Novartis India Share Price

Novartis India Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Novartis India Share Returns

  • Over 1 Month 6.07%
  • Over 3 Month 22.85%
  • Over 6 Month -4.95%
  • Over 1 Year -14.41%

Novartis India Key Statistics

P/E Ratio 41.2
PEG Ratio 0.5
Market Cap Cr 1,748
Price to Book Ratio 2.5
EPS 16.6
Dividend 2.8
Relative Strength Index 56.56
Money Flow Index 76.63
MACD Signal 20.89
Average True Range 22.48

Novartis India Investment Rating

  • Master Rating:
  • Novartis India has an operating revenue of Rs. 422.68 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 8% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 26 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Novartis India Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 121
  • 98
  • 99
  • 104
  • 98
  • 99
  • Operating Expenses Qtr Cr
  • 89
  • 93
  • 92
  • 97
  • 90
  • 84
  • Operating Profit Qtr Cr
  • 32
  • 6
  • 7
  • 7
  • 8
  • 15
  • Depreciation Qtr Cr
  • 1
  • 1
  • 3
  • 3
  • 3
  • 3
  • Interest Qtr Cr
  • 1
  • 0
  • 1
  • 2
  • 2
  • 3
  • Tax Qtr Cr
  • 4
  • -8
  • 2
  • 2
  • 4
  • 12
  • Net Profit Qtr Cr
  • 52
  • -23
  • 6
  • 7
  • 6
  • 10

Novartis India Technicals

EMA & SMA

Current Price
707.95
4.6 (0.65%)
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • 697.89
  • 50 Day
  • 667.88
  • 100 Day
  • 662.58
  • 200 Day
  • 689.28
  • 20 Day
  • 694.75
  • 50 Day
  • 652.75
  • 100 Day
  • 633.22
  • 200 Day
  • 688.89

Novartis India Resistance and Support

PIVOT
₹707.37
Resistance
  • First Resistance
  • 714.74
  • Second Resistance
  • 726.12
  • Third Resistance
  • 733.49
Support
  • First Resistance
  • 695.99
  • Second Resistance
  • 688.62
  • Third Resistance
  • 677.24
  • RSI
  • 56.56
  • MFI
  • 76.63
  • MACD Single Line
  • 20.89
  • MACD
  • 18.66

Novartis India Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 12,996
  • 716,210
  • 55.11
  • Week
  • 16,515
  • 922,349
  • 55.85
  • 1 Month
  • 51,574
  • 1,669,966
  • 32.38
  • 6 Month
  • 22,190
  • 965,508
  • 43.51

Novartis India Result Highlights

Novartis India Synopsis

NSE-Medical-Diversified

Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 399.87 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2022. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.
  • Market Cap
  • 1,748
  • Sales
  • 423
  • Shares in Float
  • 0.72
  • No of funds
  • 35
  • Yield
  • 1.41
  • Book Value
  • 2.53
  • U/D Vol ratio
  • 2.5
  • LTDebt / Equity
  • Alpha
  • -0.07
  • Beta
  • 0.67

Novartis India

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 70.68%
  • 70.68%
  • 70.68%
  • Mutual Funds
  • Insurance Companies
  • 0.76%
  • 0.76%
  • 0.76%
  • Foreign Portfolio Investors
  • 0.14%
  • 0.12%
  • 0.09%
  • Financial Institutions/ Banks
  • 0.01%
  • 0.01%
  • 0.01%
  • Individual Investors
  • 22.94%
  • 22.88%
  • 22.98%
  • Others
  • 5.47%
  • 5.55%
  • 5.48%

Novartis India Management

  • Name
  • Designation
  • Mr. Christopher Snook
  • Chairman
  • Mr. Sanjay Murdeshwar
  • Vice Chairman & Mng.Director
  • Ms. Monaz Noble
  • Non Exe.Non Ind.Director
  • Ms. Sandra Martryes
  • Independent Director
  • Mr. Jai Hiremath
  • Independent Director
  • Mr. Sanker Parameswaran
  • Independent Director

Novartis India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Novartis India Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-27
  • Quarterly Results
  • 2022-05-19
  • Audited Results & Final Dividend
  • 2022-02-10
  • Quarterly Results
  • 2021-11-11
  • Quarterly Results
  • 2021-08-11
  • Quarterly Results

Novartis India MF Shareholding

  • Name
  • Amount(cr)

Novartis India FAQs

What is Share Price of Novartis India ?

Novartis India share price is ₹707 As on 13 August, 2022 | 05:47

What is the Market Cap of Novartis India ?

The Market Cap of Novartis India is ₹1748 Cr As on 13 August, 2022 | 05:47

What is the P/E ratio of Novartis India ?

The P/E ratio of Novartis India is 41.2 As on 13 August, 2022 | 05:47

What is the PB ratio of Novartis India ?

The PB ratio of Novartis India is 2.5 As on 13 August, 2022 | 05:47

Q1FY23